Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Gyre Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +5 vs. Q4 2022
- Shares held
- 3.37M
- −1.62M (−32.5%) vs. Q4 2022
- Total value
- $707.6K
- −$1.92M (−73.1%) vs. Q4 2022
- New holders
- 9
- 10 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 875,886 | $181.0K | 0.00% | −311,100−26.2% | Reduced |
| Millennium Management LLC | 272,313 | $56.0K | 0.00% | +77,291+39.6% | Added |
| Geode Capital Management, LLC | 270,033 | $55.9K | 0.00% | −4,554−1.7% | Reduced |
| Acadian Asset Management LLC | 259,467 | $52.0K | 0.00% | +259,467 | New |
| Bank of New York Mellon Corp | 200,638 | $41.5K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 169,904 | $35.2K | 0.00% | −9,458−5.3% | Reduced |
| Nantahala Capital Management, LLC | 160,430 | $33.2K | 0.00% | −277,625−63.4% | Reduced |
| Buckingham Strategic Wealth, LLC | 43,100 | $22.7K | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 89,886 | $18.6K | 0.00% | −598−0.7% | Reduced |
| Northern Trust Corp | 86,412 | $17.9K | 0.00% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 78,612 | $16.3K | 0.00% | +61,411+357.0% | Added |
| HRT Financial LP | 81,851 | $16.0K | 0.00% | +81,851 | New |
| State Street Corp | 72,599 | $15.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 66,951 | $13.9K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 64,799 | $13.4K | 0.00% | +41,633+179.7% | Added |
| Raymond James & Associates | 62,900 | $13.0K | 0.00% | +30,380+93.4% | Added |
| Barclays PLC | 60,204 | $12.5K | 0.00% | +30,102+100.0% | Added |
| Susquehanna International Group, LLP | 58,247 | $12.1K | 0.00% | +58,247 | New |
| Two Sigma Securities, LLC | 50,750 | $10.5K | 0.00% | +10,972+27.6% | Added |
| Ergoteles LLC | 50,314 | $10.4K | 0.00% | +50,314 | New |
| Simplex Trading, LLC | 44,435 | $9.00K | 0.00% | +44,435 | New |
| Janney Montgomery Scott LLC | 40,000 | $8.00K | 0.00% | +40,000 | New |
| Morgan Stanley | 38,404 | $7.95K | 0.00% | +2,395+6.7% | Added |
| Colorado Capital Management, Inc. | 34,165 | $7.00K | 0.01% | 00.0% | Unchanged |
| HSBC Holdings PLC | 32,528 | $6.75K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 32,113 | $6.65K | 0.00% | +9,563+42.4% | Added |
| Goldman Sachs Group Inc | 21,423 | $4.43K | 0.00% | +21,423 | New |
| Keebeck Wealth Management, LLC | 20,000 | $4.14K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 15,855 | $3.28K | 0.00% | −295,861−94.9% | Reduced |
| Arete Wealth Advisors, LLC | 10,345 | $2.00K | 0.00% | +10,345 | New |
| Cutler Group LP | 5,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 1,000 | $207 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 277 | $57 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 215 | $45 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 183 | $38 | 0.00% | +3+1.7% | Added |
| Tower Research Capital LLC (TRC) | 1,377 | $0 | 0.00% | −17−1.2% | Reduced |
| JPMorgan Chase & Co | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 10 | $0 | 0.00% | +6+150.0% | Added |
| GWM Advisors LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,335,746−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −131,218−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −53,221−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −31,303−100.0% | Sold out |